Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.23.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Apr. 01, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 353,000 $ 61,000
Trade and other receivables, net 15,000 106,000
Prepaid expenses and other current assets 269,000 394,000
Current assets from discontinued operations 0 8,612,000
Total current assets 637,000 9,173,000
Other intangible assets, net 4,000 4,000
Note receivable- SPYR, net 9,175,000 8,974,000
Note receivable - VM7, net 6,052,000 0
Marketable securities 162,000 315,000
Deposits and other assets 16,000 18,000
Other assets from discontinued operations 0 8,979,000
Total assets 34,976,000 46,756,000
Liabilities:    
Accounts payable 2,664,000 2,276,000
Accrued liabilities - other 744,000 1,006,000
Short term debt 69,000 274,000
Current liabilities from discontinued operations 0 20,382,000
Total current liabilities 3,477,000 23,938,000
Deferred income taxes, net 3,153,000 0
Other noncurrent liabilities 276,000 241,000
Noncurrent liabilities from discontinued operations 0 5,760,000
Total liabilities 6,906,000 29,939,000
Commitments and contingencies (Note 15)
Stockholders' equity:    
Preferred stock, series A - par value $0.001 per share 2,000,000 authorized, 222,588and 222,588 shares issued and outstanding at April 1, 2023 and December 31 2022, respectively 0 0
Common stock, par value $0.001 per share, 10,000,000 shares authorized, 3,614,937 and 2,827,410 shares issued and outstanding at April 1, 2023 and at December 31, 2022, respectively 3,000 2,000
Additional paid in capital 46,294,000 45,748,000
Accumulated deficit (32,737,000) (42,822,000)
Accumulated other comprehensive loss 0 (621,000)
Total stockholders' equity 13,560,000 2,307,000
Total liabilities and stockholders' equity 34,976,000 46,756,000
Series S [Member]    
Stockholders' equity:    
Convertible preferred stock, series S - par value $0.001 per share 200,000 authorized,100,000 and 100,000 shares issued and outstanding at April1,2023 and December 31,2022, respectively. 14,510,000 14,510,000
Soin Therapeutics LLC Member    
Assets    
Intangible assets - Soin, net $ 18,930,000 $ 19,293,000